SALIX PHARMACEUTICALS LTD Net Cash Provided by (Used in) Operating Activities, Continuing Operations
SALIX PHARMACEUTICALS LTD reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$147.43 million for the 9-month period ending 2014-09-30, per its 10-Q/A filed 2015-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-09-30 was $10.47M, a 11.78% increase year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-06-30 was $59.28M.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities, continuing operations for the quarter ending 2014-03-31 was -$217.18M, a 202.82% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net cash provided by (used in) operating activities, continuing operations for the quarter ending 2013-09-30 was $9.37M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month as first filed |
|---|---|---|---|---|---|---|
| 2014-09-30 | $10.47M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $69.75M derived: sum of 2 quarters · filed 2015-03-02 | -$147.43M 10-Q/A · filed 2015-03-02 | -$147.36M 10-Q · filed 2014-11-07 | ||
| 2014-06-30 | $59.28M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | -$157.90M 10-Q/A · filed 2015-03-02 | -$158.86M 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | -$217.18M 10-Q/A · filed 2015-03-02 | -$190.33M 10-Q · filed 2014-05-09 | ||||
| 2013-09-30 | $9.37M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | -$135.87M derived: sum of 2 quarters · filed 2015-03-02 | $75.36M 10-Q/A · filed 2015-03-02 | |||
| 2013-06-30 | -$145.24M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $65.99M 10-Q/A · filed 2015-03-02 | ||||
| 2013-03-31 | $211.23M 10-Q/A · filed 2015-03-02 |